RADHAKISHAN PHARMACEUTICALS
HEMAZIDE  AZACITIDINE  INJECTION

HEMAZIDE AZACITIDINE INJECTION

HEMAZIDE AZACITIDINE INJECTION Specification

  • Indication
  • Indicated for the treatment of myelodysplastic syndrome and certain types of blood cancers
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Origin of Medicine
  • Allopathic
  • Dosage Form
  • Injection
  • Salt Composition
  • Azacitidine 100 mg
  • Drug Type
  • Prescription only
  • Ingredients
  • Azacitidine
  • Physical Form
  • Liquid
  • Function
  • Anticancer medication / Antineoplastic agent
  • Recommended For
  • Used in the treatment of myelodysplastic syndrome, chronic myelomonocytic leukemia, and acute myeloid leukemia
  • Dosage
  • As prescribed by the physician
  • Dosage Guidelines
  • Administer as per healthcare professionals directions
  • Suitable For
  • Adults
  • Quantity
  • 1 Vial
  • Storage Instructions
  • Store below 25C. Protect from light. Do not freeze.
  • Marketed By
  • Hemazide
  • Reconstitution
  • Requires reconstitution with sterile water for injection before use
  • Shelf Life
  • 24 months from manufacturing date
  • Product Type
  • Cytotoxic agent
  • Strength
  • 100 mg/vial
  • Method of Administration
  • Intravenous (IV) or subcutaneous injection
  • Caution
  • For hospital use only; to be administered under medical supervision
 

HEMAZIDE AZACITIDINE INJECTION Trade Information

  • Packaging Details
  • PACK OF 1 VIAL
 

About HEMAZIDE AZACITIDINE INJECTION

Specifications :-

  • Brand Name :- HEMAZIDE
  • Content:- Azacitidine
  • Strength:- 100 mg
  • Form:- injection
  • Packing:- Pack of 1 vial
  • Manufactured By :- Oncocare


Note :- HEMAZIDE Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............



Therapeutic Indications

Hemazide Azacitidine is primarily prescribed for adults suffering from myelodysplastic syndrome, chronic myelomonocytic leukemia, and acute myeloid leukemia. Its cytotoxic properties help in targeting abnormal blood cells, thereby improving hematologic function and patient outcomes. Treatment protocols are determined by the physician based on individual patient conditions.


Method of Administration

This medication is administered either intravenously or as a subcutaneous injection, following reconstitution with sterile water for injection. Administration must always be performed by qualified medical staff within healthcare settings to ensure optimal efficacy and safety for the patient.


Handling and Storage Recommendations

Proper handling is essential to preserve Hemazide Azacitidines effectiveness. Store the vial below 25C, shield it from light, and never freeze. After reconstitution, use the injection as directed and dispose of any unused solution safely according to institutional guidelines for cytotoxic substances.

FAQs of HEMAZIDE AZACITIDINE INJECTION:


Q: How is HEMAZIDE Azacitidine Injection prepared and administered?

A: Hemazide Azacitidine Injection must be reconstituted with sterile water for injection by a medical professional before administration. It is then administered either intravenously or subcutaneously, strictly in a hospital setting under medical supervision.

Q: What conditions is HEMAZIDE Azacitidine Injection used to treat?

A: This medication is indicated for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukemia, and acute myeloid leukemia in adults, as recommended by healthcare professionals.

Q: When should HEMAZIDE Azacitidine Injection be given to patients?

A: Administration is based on your physicians prescribed schedule, which considers the specific diagnosis and response to therapy. Only a qualified healthcare provider should determine when and how often the injection is given.

Q: Where should HEMAZIDE Azacitidine Injection be stored?

A: The vials should be stored below 25C in a location protected from light. They must not be frozen. Ensure storage is in accordance with hospital guidelines for cytotoxic medications.

Q: What benefits does HEMAZIDE Azacitidine Injection provide?

A: Hemazide Azacitidine works as an antineoplastic agent to inhibit the growth of abnormal blood cells, helping to improve blood counts and reduce disease progression in selected hematologic cancers.

Q: Who is allowed to administer HEMAZIDE Azacitidine Injection?

A: Only licensed healthcare professionals within hospital environments are permitted to prepare and administer this drug, due to its potent cytotoxic nature and specialized dosing requirements.

Q: Is HEMAZIDE Azacitidine Injection suitable for self-administration at home?

A: No, Hemazide Azacitidine Injection must only be administered in healthcare settings under professional supervision. It is not safe for home or unsupervised use due to the need for specialized preparation and monitoring.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS

ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS

Recommended For : Prostate Cancer Patients

Dosage Guidelines : Should be taken on an empty stomach, at least one hour before or two hours after food

Dosage : As prescribed by the physician, typically 1000 mg (4 tablets) once daily

Ingredients : Abiraterone Acetate

Physical Form : Other, Tablet

Suitable For : Adults

RESOF TOTAL SOFOSBUVIR AND VELPATASVIR  TABLETS

RESOF TOTAL SOFOSBUVIR AND VELPATASVIR TABLETS

Recommended For : Treatment of chronic Hepatitis C infection

Dosage Guidelines : Once daily, orally

Dosage : As directed by physician

Ingredients : Sofosbuvir and Velpatasvir

Physical Form : Tablets

Suitable For : Adults

ERLOCIP ARLOTINIB 150 MG TABLETS

ERLOCIP ARLOTINIB 150 MG TABLETS

Recommended For : NonSmall Cell Lung Cancer (NSCLC) and Pancreatic Cancer Patients

Dosage Guidelines : As directed by physician

Dosage : 100mg , 150 mg

Ingredients : Erlotinib Hydrochloride

Physical Form : Tablets

Suitable For : Adults

RESOF AND HEPCFIX SOFOSBUVIR TABLETS

RESOF AND HEPCFIX SOFOSBUVIR TABLETS

Recommended For : Chronic Hepatitis C Virus Infection

Dosage Guidelines : Take orally once daily

Dosage : As directed by physician

Ingredients : Sofosbuvir & Daclatasvir

Physical Form : Tablets

Suitable For : Adults



Back to top